171 related articles for article (PubMed ID: 28710963)
1. 2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer.
Zhang X; Bian J; Li X; Wu X; Dong Y; You Q
Eur J Med Chem; 2017 Sep; 138():616-629. PubMed ID: 28710963
[TBL] [Abstract][Full Text] [Related]
2. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
[TBL] [Abstract][Full Text] [Related]
3. Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile.
Bian J; Li X; Wang N; Wu X; You Q; Zhang X
Eur J Med Chem; 2017 Mar; 129():27-40. PubMed ID: 28214631
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.
Wu X; Li X; Li Z; Yu Y; You Q; Zhang X
J Med Chem; 2018 Dec; 61(24):11280-11297. PubMed ID: 30508483
[TBL] [Abstract][Full Text] [Related]
5. Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.
Ling Y; Yang QX; Teng YN; Chen S; Gao WJ; Guo J; Hsu PL; Liu Y; Morris-Natschke SL; Hung CC; Lee KH
Eur J Med Chem; 2018 Jun; 154():199-209. PubMed ID: 29803003
[TBL] [Abstract][Full Text] [Related]
6. Simple 2(5H)-furanone derivatives with selective cytotoxicity towards non-small cell lung cancer cell line A549 - Synthesis, structure-activity relationship and biological evaluation.
Byczek-Wyrostek A; Kitel R; Rumak K; Skonieczna M; Kasprzycka A; Walczak K
Eur J Med Chem; 2018 Apr; 150():687-697. PubMed ID: 29571156
[TBL] [Abstract][Full Text] [Related]
7. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranones derivatives.
Lardic M; Patry C; Duflos M; Guillon J; Massip S; Cruzalegui F; Edmonds T; Giraudet S; Marini L; Leonce S
J Enzyme Inhib Med Chem; 2006 Jun; 21(3):313-25. PubMed ID: 16918079
[TBL] [Abstract][Full Text] [Related]
9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
10. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
[TBL] [Abstract][Full Text] [Related]
11. Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC.
Madajewski B; Boatman MA; Chakrabarti G; Boothman DA; Bey EA
Mol Cancer Res; 2016 Jan; 14(1):14-25. PubMed ID: 26553038
[TBL] [Abstract][Full Text] [Related]
12. An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer.
Liu F; Yu G; Wang G; Liu H; Wu X; Wang Q; Liu M; Liao K; Wu M; Cheng X; Hao H
PLoS One; 2012; 7(7):e42138. PubMed ID: 22848731
[TBL] [Abstract][Full Text] [Related]
13. Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis.
Yu J; Zhong B; Zhao L; Hou Y; Ai N; Lu JJ; Ge W; Chen X
Drug Resist Updat; 2023 Sep; 70():100977. PubMed ID: 37321064
[TBL] [Abstract][Full Text] [Related]
14. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
[TBL] [Abstract][Full Text] [Related]
15. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
16. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
17. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
Kolossov VL; Ponnuraj N; Beaudoin JN; Leslie MT; Kenis PJ; Gaskins HR
Biochem Biophys Res Commun; 2017 Jan; 483(1):680-686. PubMed ID: 27986568
[TBL] [Abstract][Full Text] [Related]
18. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1.
Hassani M; Cai W; Holley DC; Lineswala JP; Maharjan BR; Ebrahimian GR; Seradj H; Stocksdale MG; Mohammadi F; Marvin CC; Gerdes JM; Beall HD; Behforouz M
J Med Chem; 2005 Dec; 48(24):7733-49. PubMed ID: 16302813
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents.
Wu LQ; Ma X; Liu ZP
Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133
[TBL] [Abstract][Full Text] [Related]
20. Dihydrithieno[2,3-b]naphto-4,9-dione analogues as anticancer agents: Synthesis and in cell pharmacological studies.
Bertamino A; Musella S; Di Sarno V; Ostacolo C; Manfra M; Vanacore D; Stiuso P; Novellino E; Campiglia P; Gomez-Monterrey IM
Eur J Med Chem; 2015 Sep; 102():106-14. PubMed ID: 26253231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
